. Patients with hyperthyroidism may exhibit accelerated platelet turnover, shortened platelet survival and, consequently, mildly reduced peripheral platelet counts, the latter usually being subclinical (5-7). Based on studies in humans and animal models, increased platelet destruction by an activated reticuloendothelial system has been attributed a pivotal role in the increased platelet turnover associated with hyper¬ thyroidism (6, 8 (12) (13) (14) (15) . Administration of warfarin may be indicated in patients with persistent hyperthyroidism-related atrial fibrillation who are older than 60 years, and who present with heart failure and organic heart disease, especially when combined with an enlarged left atrium (14, 15) . By contrast, acute atrial fibrillation in younger patients without underlying heart disease does not usually necessitate administration of warfarin (12, 14, 15) . No data have yet become available regarding usage of aspirin as an alternative anticoagulant under these circumstances. (19) (20) (21) ). Follow-up studies in patients with AITP indicated that hyperthyroidism developed in 8-14% of patients (19, 20 (17, (24) (25) (26) . Further, Graves' disease and AITP may coincide with malignancy (27) or other autoimmune diseases such as myasthenia gravis (28, 29) , insulin-dependent diabetes mellitus (30) , and the Evans' syndrome (31), a disorder characterized by autoimmune hemolytic anemia, AITP, and the presence of a positive direct antiglobulin test. In addition, the Evans' syndrome may also be associated with Hashimoto's thyroiditis (32 (37) .
In addition, AITP has also been reported in patients with Hashimoto's thyroiditis (16, 38) , and both diseases may further be associated with myasthenia gravis (39, 40 (64, 65) , thrombomodulin (66) and endothelin-1 (67) . In addition, increased de novo synthesis of von Willebrand factor and factor VIII in hypothyroid patients following thyroid hormone replacement may also result from non-specific stimulation of hepatic protein synthesis by thyroid hormone (55) .
In (56) . Impaired clearance of these factors may explain the clinical observation that higher doses of warfarin may be required to achieve appropriate anticoagulation in hypothyroidism (56 
